By Eric Schillinger and Anne Tyler Hall


- Expanding the health care nondiscrimination rules under Section 1557 of the Patient Protection and Affordable Care Act;
- Withdrawing the rules for association health plans issued by the Trump administration, which are currently under dispute in the federal court system;
- Issuing regulations implementing the tax nondiscrimination rules for insured group health plans added by the ACA;
- Expanding the mental health parity requirements for group health plans regarding the coverage of mental health and substance use benefits on similar terms as medical and surgical benefits;
- Introducing legislation expanding the scope and availability of ACA subsidies — referred to as premium tax credits — for individual plans on the federal and state ACA health insurance exchanges; and
- Restoring the ACA’s individual mandate penalty to protect the ACA from potentially being struck down in the upcoming consolidated U.S. Supreme Court cases, California v. Texas and Texas v. California, if Democrats gain control of the Senate and retain their house majority.
- Making the ACA subsidy more generous by basing the subsidy amount on the richer gold plan (rather than the silver plan) on the ACA exchange;
- Lowering the affordability threshold used to determine subsidy eligibility and amounts, which is based on a percentage of the individual’s household income;
- Removing the prohibition of those who are offered affordable, minimum-value employer-sponsored coverage from receiving ACA subsidies;
- Allowing Medicare to directly negotiate drug prices;
- Allowing the importation of prescription drugs from abroad; and
- The creation of a public option as another source of health care for Americans — sometimes referred to as “Medicare for all who want it” — which would also be available to those with employer-sponsored coverage.